- Home
- ESPR vs OMI Comparison
ESPR vs OMI Comparison
Compare ESPR & OMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- OMI
- Stock Information
- Founded
- ESPR 2008
- OMI 1882
- Country
- ESPR United States
- OMI United States
- Employees
- ESPR N/A
- OMI N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- OMI Medical Specialities
- Sector
- ESPR Health Care
- OMI Health Care
- Exchange
- ESPR Nasdaq
- OMI Nasdaq
- Market Cap
- ESPR 445.6M
- OMI 415.6M
- IPO Year
- ESPR 2013
- OMI N/A
- Fundamental
- Price
- ESPR $2.76
- OMI $5.30
- Analyst Decision
- ESPR Buy
- OMI Hold
- Analyst Count
- ESPR 6
- OMI 7
- Target Price
- ESPR $6.50
- OMI $7.96
- AVG Volume (30 Days)
- ESPR 6.0M
- OMI 1.9M
- Earning Date
- ESPR 11-06-2025
- OMI 11-03-2025
- Dividend Yield
- ESPR N/A
- OMI N/A
- EPS Growth
- ESPR N/A
- OMI N/A
- EPS
- ESPR N/A
- OMI N/A
- Revenue
- ESPR $268,125,000.00
- OMI $10,758,440,000.00
- Revenue This Year
- ESPR $9.87
- OMI N/A
- Revenue Next Year
- ESPR N/A
- OMI N/A
- P/E Ratio
- ESPR N/A
- OMI N/A
- Revenue Growth
- ESPR N/A
- OMI 64.35
- 52 Week Low
- ESPR $0.69
- OMI $4.56
- 52 Week High
- ESPR $3.94
- OMI $16.47
- Technical
- Relative Strength Index (RSI)
- ESPR 71.69
- OMI 45.16
- Support Level
- ESPR $2.69
- OMI $4.90
- Resistance Level
- ESPR $2.85
- OMI $5.64
- Average True Range (ATR)
- ESPR 0.17
- OMI 0.35
- MACD
- ESPR -0.00
- OMI 0.07
- Stochastic Oscillator
- ESPR 82.72
- OMI 60.00
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About OMI Owens & Minor Inc.
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.